Aqualung Therapeutics Corp. Awarded $300 Thousand From National Institute of Health (NIH) to Develop a Novel Therapeutic for Pregnant Women at Risk for Preterm Births
TUCSON, AZ / ACCESSWIRE / September 22, 2020 / Aqualung Therapeutics, an early-stage biotech company…
TMX Group Thanksgiving Holiday Market Closures
TIPAK Marks Path to Leadership in Packaging Solutions Following Listing on SET
Chervon Names Daniel L. Abbott Director of Sales – Western U.S.A.
Chervon Names Peter J. Carlson Director of Sales for Strategic Accounts
Chervon Appoints Neil Harrison to the Position of VP Sales, Marketing and MD for Chervon Canada